Paulo Joao A, Kadiyala Vivek, Gaun Aleksandr, Sauld John F K, Ghoulidi Ali, Banks Peter A, Steen Hanno, Conwell Darwin L
Department of Pathology, Children's Hospital Boston and Harvard Medical School, Boston, MA 02115, USA.
JOP. 2013 Mar 10;14(2):176-86. doi: 10.6092/1590-8577/1272.
We have shown previously that trichloroacetic acid precipitation is an effective method of protein extraction from pancreatic fluid for downstream biomarker discovery, compared to other common extraction methods tested.
We aim to assess the utility of ultracentrifugation as an alternative method of protein extraction from pancreatic fluid.
Proteins extracted from trichloroacetic acid- and ultracentrifugation-precipitated pancreatic fluid were identified using mass spectrometry techniques (in-gel tryptic digestion followed by liquid chromatography-tandem mass spectrometry; GeLC-MS/MS). Data were analyzed using Proteome Discoverer and Scaffold 3.
This is a proteomic analysis experiment of endoscopically collected fluid in an academic center.
The study population included adult patients referred to the Center for Pancreatic Disease at Brigham and Women's Hospital, Boston, MA, USA for the evaluation of abdominal pain and gastrointestinal symptoms.
Secretin-stimulated pancreatic fluid was collected as standard of care for the evaluation of abdominal pain and gastrointestinal symptoms.
We compared proteins identified via standard trichloroacetic acid precipitation and this alternative ultracentrifugation strategy.
A subset of pancreatic fluid proteins was identified via the ultracentrifugation method. Of these proteins, similar numbers were obtained from fully tryptic or semi-tryptic database searching. Proteins identified in the ultracentrifugation-precipitated samples included previously identified biomarker candidates of chronic pancreatitis.
This alternative ultracentrifugation strategy requires less time and fewer handling procedures than standard trichloroacetic acid precipitation, at the expense of higher sample volume. As such, this method is well suited for targeted assays (i.e., dot blotting or targeted mass spectrometry) if the protein of interest is among those readily identified by ultracentrifugation-promoted precipitation.
我们之前已经表明,与测试的其他常见提取方法相比,三氯乙酸沉淀是一种从胰液中提取蛋白质以用于下游生物标志物发现的有效方法。
我们旨在评估超速离心作为从胰液中提取蛋白质的替代方法的实用性。
使用质谱技术(凝胶内胰蛋白酶消化,然后进行液相色谱 - 串联质谱;GeLC - MS/MS)鉴定从三氯乙酸沉淀和超速离心沉淀的胰液中提取的蛋白质。使用Proteome Discoverer和Scaffold 3分析数据。
这是一项在学术中心对内镜收集的液体进行的蛋白质组分析实验。
研究人群包括因腹痛和胃肠道症状转诊至美国马萨诸塞州波士顿布莱根妇女医院胰腺疾病中心的成年患者。
收集促胰液素刺激的胰液作为评估腹痛和胃肠道症状的标准治疗方法。
我们比较了通过标准三氯乙酸沉淀和这种替代超速离心策略鉴定的蛋白质。
通过超速离心法鉴定了一部分胰液蛋白质。在这些蛋白质中,通过完全胰蛋白酶或半胰蛋白酶数据库搜索获得的数量相似。在超速离心沉淀样品中鉴定出的蛋白质包括先前确定的慢性胰腺炎生物标志物候选物。
这种替代超速离心策略比标准三氯乙酸沉淀所需时间更少,操作步骤更少,但代价是样品体积更大。因此,如果感兴趣的蛋白质是通过超速离心促进沉淀容易鉴定的蛋白质之一,那么这种方法非常适合靶向分析(即斑点印迹或靶向质谱)。